{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:50:00Z","timestamp":1782723000068,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016304","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011948","name":"Abbott Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hrthm.2026.03.1885","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:41:19Z","timestamp":1773909679000},"page":"1453-1464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety of catheter ablation compared with antiarrhythmic drugs for atrial fibrillation: A systematic review and meta-analysis of randomized trials"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6053-5523","authenticated-orcid":false,"given":"Marwan","family":"Shawki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalys Sampaio","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mandrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason G.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han S.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1935-8155","authenticated-orcid":false,"given":"Gareth J.","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2026.03.1885_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCULATIONAHA.105.548206","article-title":"Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age","volume":"113","author":"Lloyd-Jones","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs. antiarrhythmic drugs: First-Line Therapy for Patients with Paroxysmal atrial fibrillation","volume":"23","author":"Kuniss","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib7","article-title":"Gender, ethnic, and socioeconomic differences in access to catheter ablation therapy in patients with atrial fibrillation","volume":"9","author":"Hamade","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib8","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2459\/JCM.0b013e328332e926","article-title":"Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: A meta-analysis of randomized trials","volume":"11","author":"Bonanno","year":"2010","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amjcard.2023.11.052","article-title":"Ablation versus antiarrhythmic drugs as first-line therapy for treatment-naive atrial fibrillation: A systematic review and meta-analysis","volume":"213","author":"Ullah","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.56086","article-title":"Factors associated with primary care physician decision-making when making medication recommendations vs surgical referrals","volume":"6","author":"Naik","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1748-5908-4-54","article-title":"Why don\u2019t Physicians Adhere to Guideline Recommendations in Practice? An analysis of barriers among Dutch general practitioners","volume":"4","author":"Lugtenberg","year":"2009","journal-title":"Implement Sci"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11695-019-04204-9","article-title":"Primary care physicians\u2019 perceptions of bariatric surgery and major barriers to referral","volume":"30","author":"Conaty","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2147\/PPA.S143958","article-title":"Aversion to ambiguity and willingness to take risks affect therapeutic decisions in managing atrial fibrillation for stroke prevention: results of a pilot study in family physicians","volume":"11","author":"Raptis","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study","volume":"109","author":"Investigators","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib17","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2024"},{"issue":"suppl 1","key":"10.1016\/j.hrthm.2026.03.1885_bib18","first-page":"S8","article-title":"A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation","volume":"86","author":"Krittayaphong","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib19","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","article-title":"Catheter ablation treatment in patients with drug-refractory atrial fibrillation: A prospective, multi-centre, randomized, controlled study (catheter ablation for the cure of atrial fibrillation study)","volume":"27","author":"Stabile","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJMoa050955","article-title":"Circumferential pulmonary-vein ablation for chronic atrial fibrillation","volume":"354","author":"Oral","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib21","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation","volume":"118","author":"Ja\u00efs","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1540-8167.2008.01275.x","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus Type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy","volume":"20","author":"Forleo","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radio-frequency catheter ablation in patients with paroxysmal atrial fibrillation","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCEP.111.966408","article-title":"Radio-frequency catheter ablation and antiarrhythmic drug therapy","volume":"4","author":"Pappone","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/heartjnl-2016-309781","article-title":"Long-term efficacy of catheter ablation as first-line therapy for paroxysmal Atrial Fibrillation: 5-Year Outcome in a Randomised Clinical Trial","volume":"103","author":"Nielsen","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","article-title":"Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American arctic front (STOP AF) pivotal trial","volume":"61","author":"Packer","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.hrthm.2013.11.009","article-title":"Phased RF ablation in persistent atrial fibrillation","volume":"11","author":"Hummel","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic Drug Treatment of Persistent atrial fibrillation: A Multicentre, Randomized, Controlled Trial (SARA study)","volume":"35","author":"Mont","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic Drugs as First-Line Treatment of Paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib28","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jacc.2016.10.037","article-title":"HotBalloon ablation of the pulmonary veins for paroxysmal AF: A multicenter randomized trial in Japan","volume":"68","author":"Sohara","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib30","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/europace\/euaa356","article-title":"Long-Term Observation of Catheter ablation vs. pharmacotherapy in the Management of Persistent and Long-Standing Persistent atrial fibrillation (CAPA study)","volume":"23","author":"Wu","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib34","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/europace\/euac253","article-title":"Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: A prospective, randomized, multi-centre, open label trial","volume":"25","author":"Kanagaratnam","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib35","doi-asserted-by":"crossref","DOI":"10.36660\/abc.20230684","article-title":"Estudo Randomizado Comparando a Abla\u00e7\u00e3o por Cateter com o PVAC Gold vs. Tratamento com F\u00e1rmacos Antiarr\u00edtmicos em Pacientes Idosos com Fibrila\u00e7\u00e3o Atrial Sintom\u00e1tica","volume":"121","author":"Martins","year":"2024","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib39","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jce.12404","article-title":"Improving safety in catheter ablation for atrial fibrillation: A prospective study of the use of ultrasound to guide vascular access","volume":"25","author":"Wynn","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib40","first-page":"241","article-title":"Factors impacting complication rates for catheter ablation of atrial fibrillation from 2003 to 2015","volume":"19","author":"Yang","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib41","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jacc.2023.03.418","article-title":"Procedure-related complications of catheter ablation for atrial fibrillation","volume":"81","author":"Benali","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007944","article-title":"Procedural patterns and safety of atrial fibrillation ablation: findings from get with the guidelines-atrial fibrillation","volume":"13","author":"Loring","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib43","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/CIRCEP.113.000768","article-title":"Complications of catheter ablation of atrial fibrillation: A systematic review","volume":"6","author":"Gupta","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib44","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/europace\/euaa415","article-title":"Relationship between procedural volume and complication rates for catheter ablation of atrial fibrillation: A systematic review and meta-analysis","volume":"23","author":"Tonchev","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib45","first-page":"85","article-title":"The association between atrial fibrillation burden and quality of life: A substudy of the SHAM-PVI trial","volume":"12","author":"Dulai","year":"2026","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib46","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/europace\/eux356","article-title":"Burden of atrial high-rate episodes and risk of stroke: a systematic review","volume":"20","author":"Uittenbogaart","year":"2018","journal-title":"Europace"},{"issue":"24","key":"10.1016\/j.hrthm.2026.03.1885_bib47","article-title":"Catheter ablation of paroxysmal atrial fibrillation and disease progression: magnitude of the antiprogression effect and role of intervention timing","volume":"S1547-5271","author":"Benali","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005049.pub5","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","author":"Valembois","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib49","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib50","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7326\/M13-1467","article-title":"Rate- and rhythm-control therapies in patients with atrial fibrillation","volume":"160","author":"Al-Khatib","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0735-1097(92)90003-6","article-title":"Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation","volume":"20","author":"Flaker","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib52","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","article-title":"Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs","volume":"270","author":"Makkar","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib53","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/europace\/euv233","article-title":"Cardiac tachyarrhythmias and patient values and preferences for their management: The European Heart Rhythm Association (EHRA) Consensus Document Endorsed by the Heart Rhythm Society (HRS)","volume":"17","author":"Lane","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib54","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/hs0102.101817","article-title":"Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy","volume":"33","author":"Lip","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2648.2007.04465.x","article-title":"Patient knowledge of atrial fibrillation: 3-month follow-up after an emergency room visit","volume":"61","author":"Koponen","year":"2008","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib56","first-page":"1747","article-title":"NEMESIS-PFA: investigating collateral tissue injury associated with pulsed field ablation","volume":"11","author":"Lakkireddy","year":"2025","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib57","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","article-title":"Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation","volume":"389","author":"Reddy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2026.03.1885_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation","volume":"83","author":"Joglar","year":"2023","journal-title":"J Am Coll Cardiol 2024"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126021417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126021417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:41:26Z","timestamp":1782722486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126021417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1547527126021417"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.03.1885","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of catheter ablation compared with antiarrhythmic drugs for atrial fibrillation: A systematic review and meta-analysis of randomized trials","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.03.1885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.03.1886","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}